Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gencor Industries (GENC) Asset Writedowns and Impairment (2016 - 2025)

Gencor Industries' Asset Writedowns and Impairment history spans 15 years, with the latest figure at $95000.0 for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment changed N/A year-over-year to $95000.0; the TTM value through Dec 2025 reached $95000.0, down 45.71%, while the annual FY2025 figure was $50000.0, N/A changed from the prior year.
  • Asset Writedowns and Impairment reached $95000.0 in Q4 2025 per GENC's latest filing, down from $175000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $175000.0 in Q2 2023 to a low of -$75000.0 in Q3 2021.
  • Average Asset Writedowns and Impairment over 4 years is $62900.0, with a median of $70000.0 recorded in 2021.
  • Peak YoY movement for Asset Writedowns and Impairment: surged 300.0% in 2021, then crashed 35.0% in 2022.
  • A 4-year view of Asset Writedowns and Impairment shows it stood at $75000.0 in 2021, then changed by 0.0% to $75000.0 in 2022, then surged by 133.33% to $175000.0 in 2023, then tumbled by 45.71% to $95000.0 in 2025.
  • Per Business Quant, the three most recent readings for GENC's Asset Writedowns and Impairment are $95000.0 (Q4 2025), $175000.0 (Q2 2023), and $40000.0 (Q1 2023).